Practice question

Answer the question and get instant feedback.

MediumCardiologyHeart Failure with Reduced EFukmlamrcp part 1mrcgp aktpaneprescribing safety assessment

A 68-year-old with HFrEF (LVEF 30%) is on ACE inhibitor, beta-blocker and spironolactone. Symptoms persist (NYHA II). What additional disease-modifying therapy is recommended?

Educational content. Not a substitute for clinical judgement or local policy.